Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine

Corey M Peak, Hil Lyons, Arend Voorman, Elizabeth J Gray, Laura V Cooper, Isobel M Blake, Kaija M Hawes, Ananda S Bandyopadhyay, Antonio Toniolo · 2024

Read Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine by Corey M Peak, Hil Lyons, Arend Voorman, Elizabeth J Gray, Laura V Cooper, Isobel M Blake, Kaija M Hawes, Ananda S Bandyopadhyay, Antonio Toniolo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11680014.txt.

Description

Corey Peak and co-authors published a study in 2024 on the risk that a new polio vaccine could itself spark new outbreaks. The older oral vaccine used a live but weak virus that could, in places with low coverage, change and spread. The new vaccine was built to be more stable. The team asked how much lower the risk is with the new type.

Using campaign data from May 2016 to August 2024 and records of virus finds, the authors count what would be expected under the old vaccine. They estimate far fewer new outbreaks arose with the new vaccine in Africa, about four times fewer. The finding matches lab and field signs that the new vaccine stays more stable.

Catalog record

CREATORCorey M Peak, Hil Lyons, Arend Voorman, Elizabeth J Gray, Laura V Cooper, Isobel M Blake, Kaija M Hawes, Ananda S Bandyopadhyay, Antonio Toniolo
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11680014

Browse the full library · About the Tower of Babel